AbbVie to acquire Landos Biopharma to bolster autoimmune disease treatments

AbbVie Inc. (NYSE: ABBV) and Landos Biopharma, Inc. (NASDAQ: LABP) have announced a landmark agreement, marking a strategic move in the biopharmaceutical sector focused on ... Read More